DILORA – M Tablet

 Defeats Excruciating Allergies

COMPOSITION: Desloratadine 5mg + Montelukast 10 mg


Desloratadine (Antihistamine)

  • Desloratadine, is a potent, nonsedating H1-receptor antagonist with antiallergic and anti-inflammatory properties.
  • Desloratadine is safe and is associated with a statistically significant reduction in nasal and nonnasal symptoms in patients with perennial allergic rhinitis.
  • Was superior to placebo in controlling pruritus & total symptoms after the first dose and maintained this superiority to the end of the study.
  • 5 mg daily is a safe and effective treatment for chronic idiopathic urticarial with significant benefits. 

Montelukast (Leukotriene receptor antagonists)

  • Montelukast, a novel medication, is an antagonist to the leukotriene receptor, a viable alternative for the treatment of seasonal allergic rhinitis.
  • Rapidly absorbed achieving peak plasma concentration, well tolerated, and has a safety profile similar in pediatric and adult populations.
  • Has benefits equivalent to antihistamines when used as monotherapy regarding efficacy and quality of life improvement and may be equivalent to intranasal corticosteroids, at least in some patients.


  • In the treatment of bronchoconstriction resulting from early asthmatic response to an inhaled allergen the combination of Desloratadine and Montelukast provides superior efficacy to either blocker administered alone. 
  • The combination of Desloratadine and Montelukast is effective in the treatment of chronic urticaria. This combination improves the symptoms and patient’s quality of life significantly more than desloratadine alone.


Desloratadine 5mg + Montelukast 10 mg


  1. Seasonal allergic rhinitis
  2. Asthma
  3. Chronic urticarial
  4. Pruritus (itchy skin)